Search results
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 52 minutes agoResearchers in the US have developed a molecule that “appears to annihilate all solid tumours” in...
Tumor infiltrating lymphocyte approval heralds new era for precision cancer immunotherapy
Nature· 1 day agoFDA approval of Iovance’s lifileucel for melanoma shows the promise of tumor-infiltrating lymphocytes for the treatment of solid tumors, with trials ongoing ...
Summit reports data from Phase III NSCLC treatment trial
Clinical Trials Arena via Yahoo Finance· 1 hour ago“We want to congratulate our partners at Akeso for this incredible result and their work to advance...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 13 hours ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
...Ifebemtinib in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C...
WKBN 27 Youngstown· 1 day ago... 30, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, today announced results from the Phase Ib/II clinical trial of ifebemtinib, the company's focal adhesion kinase (FAK) inhibitor, in...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 15 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...
WROC Rochester· 3 days agoData from a first-in-human study of ABBV-706, a potential best-in-class SEZ6 directed ADC, in small cell lung cancer (SCLC), high-grade central nervous ...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 days agoBMS-986218’s PTSR also decreased by 18 points in non-small cell lung cancer (NSCLC), reaching 20%....
FDA fast tracks lung cancer treatment by Affimed By Investing.com
Investing.com· 2 days agoThe U.S. Food and Drug Administration (FDA) has granted Fast Track designation to a novel lung ...
FDA grants IND clearance for Abdera’s Phase I cancer therapy trial
Clinical Trials Arena via Yahoo Finance· 7 days agoThe upcoming, first-in-human, open-label study will assess...radiopharmaceutical biologic therapy,...